Saxenda Shortage: Current Status by Strength and What to Do

Partly. Liraglutide: A current shortage is still listed. Generic versions are available, while Victoza pens are in limited supply. Saxenda is being discontinued in January 2027.

Shortage: Some products short
Prescription: RequiredFDA label (DailyMed)

Saxenda in brief

How long it remains in your body

About 13 hours is the half-life: after 13 h half is gone, and after five half-lives (2.7 d) about 3% is left.

Main trial weight results

During the SCALE Obesity and Prediabetes, 56 weeks trial, the figures were 7.4% of body weight compared with 3% on placebo.

FDA label on DailyMed required

Every legitimate route to Saxenda, ranked

Prices checked November 2026. Each price links to the page it came from.

Sources: Novo Nordisk pricing, NovoCare, api.fda.gov.

Who qualifies

Every GLP-1 medicine sold in the US needs a prescription. A prescriber writes the prescription when the use is approved on the label:

This helps you lose weight and keep it off long term, for people 12 and older (over 60 kg) who have obesity. Adults who have overweight plus a weight-related condition are covered too. Diet and activity go along with it.

Source: FDA label (DailyMed).

Shortage status

Liraglutide: A current shortage is still listed. Generic versions are available, while Victoza pens are in limited supply. Saxenda is being discontinued in January 2027.

Liraglutide availability, product by product
Product	FDA status	Availability
Saxenda 6 mg/mL pen (5-pack)	To Be Discontinued	Available until January 2027

It first appeared on the FDA shortage list on July 18, 2023

Sources: api.fda.gov, ashp.org.

Scam signals

No prescription needed: skipping the prescription means a seller cannot be a licensed US pharmacy.
Sold as the brand: a compounded drug has no FDA approval, so it is not Ozempic, Wegovy, Mounjaro nor Zepbound.
Some telehealth companies made misleading claims, including that a product matched the brand. The FDA sent them 30 warning letters.
A monthly price with no drug included: the FTC acted against one program over this practice.

Sources: Novo Nordisk pricing, NovoCare, FDA.

Where to find it in your state

Hims & Hers: 50 states, with no availability in some of them
Some of the 50 states do not have Noom Med available
NovoCare Pharmacy: its delivery network covers all 50 states, DC, Puerto Rico

The route changes most because of Medicaid rules. GLP-1s for weight loss are covered by 10 state Medicaid programs at this time. Pick your state to see its drug list and prior authorization rules:

Sources: hims.com, noom.com, NovoCare.